1887

Abstract

The prebiotic Bimuno is a mixture containing galactooligosaccharide, produced by the galactosyltransferase activity of NCIMB 41171 in the presence of lactose. Previous studies have implicated prebiotics in reducing infections by enteric pathogens, thus it was hypothesized that Bimuno may confer some protection in the murine host from serovar Typhimurium ( Typhimurium) infection. In this study, infection caused by Typhimurium SL1344nal in the presence or absence of Bimuno was assessed using tissue culture assays, a murine ligated ileal gut loop model and a murine oral challenge model. In tissue culture adherence and invasion assays with HT-29-16E cells, the presence of ∼2 mM Bimuno significantly reduced the invasion of Typhimurium SL1344nal (<0.0001). In the murine ligated ileal gut loops, the presence of Bimuno prevented colonization and the associated pathology of Typhimurium. In the BALB/c mouse model, the oral delivery of Bimuno prior to challenge with Typhimurium resulted in significant reductions in colonization in the five organs sampled, with highly significant reductions being observed in the spleen at 72 and 96 h post-challenge (=0.0002, <0.0001, respectively). Collectively, the results indicate that Bimuno significantly reduced the colonization and pathology associated with Typhimurium infection in a murine model system, possibly by reducing the invasion of the pathogen into host cells.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.004390-0
2009-01-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/1/37.html?itemId=/content/journal/jmm/10.1099/jmm.0.004390-0&mimeType=html&fmt=ahah

References

  1. Agunos A., Ibuki M., Yokomizo F., Mine Y. 2007; Effect of dietary β 1-4 mannobiose in the prevention of Salmonella enteritidis infection in broilers. Br Poult Sci 48:331–341 [CrossRef]
    [Google Scholar]
  2. Anthony J. C., Merriman T. N., Heimbach J. T. 2006; 90-Day oral (gavage) study in rats with galactooligosaccharides syrup. Food Chem Toxicol 44:819–826 [CrossRef]
    [Google Scholar]
  3. Arslanoglu S., Moro G., Boehm G. 2007; Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr 137:2420–2424
    [Google Scholar]
  4. Bailey J. S., Blankenship L. C., Cox N. A. 1991; Effect of fructooligosaccharide on Salmonella colonization of the chicken intestine. Poult Sci 70:2433–2438 [CrossRef]
    [Google Scholar]
  5. Boehm G., Jelinek J., Stahl B., van Laere K., Knol J., Fanaro S., Moro G., Vigi V. 2004; Prebiotics in infant formulas. J Clin Gastroenterol 38:S76–S79 [CrossRef]
    [Google Scholar]
  6. Carlson S. A., Stoffregen W. C., Bolin S. R. 2002; Abomasitis associated with multiple antibiotic resistant Salmonella enterica serotype Typhimurium phagetype DT104. Vet Microbiol 85:233–240 [CrossRef]
    [Google Scholar]
  7. Castanon J. I. 2007; History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci 86:2466–2471 [CrossRef]
    [Google Scholar]
  8. Collins M. D., Gibson G. R. 1999; Probiotics, prebiotics and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69:1052S–1057S
    [Google Scholar]
  9. Coppa G. V., Bruni S., Morelli L., Soldi S., Gabrielli O. 2004; The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 38:S80–S83 [CrossRef]
    [Google Scholar]
  10. Depeint F., Tzortzis G., Vulevic J., l'Anson K., Gibson G. R. 2008; Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87:785–791
    [Google Scholar]
  11. Dunlap N. E., Benjamin W. H. Jr, McCall R. D. Jr, Tilden A. B., Briles D. E. 1991; A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb Pathog 10:297–310 [CrossRef]
    [Google Scholar]
  12. Gibson G. R., Roberfroid M. B. 1995; Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
    [Google Scholar]
  13. Gibson G. R., McCartney A. L., Rastall R. A. 2005; Prebiotics and resistance to gastrointestinal infections. Br J Nutr 93:S31–S34 [CrossRef]
    [Google Scholar]
  14. Girard F., Frankel G., Phillips A. D., Cooley W., Weyer U., Dugdale A. H. A., Woodward M. J., La Ragione R. M. 2008; Interaction of enterohemorrhagic Escherichia coli O157 : H7 with mouse intestinal mucosa. FEMS Microbiol Lett 283:196–202 [CrossRef]
    [Google Scholar]
  15. Hald T. 2001; Salmonella in pork – epidemiology, control and the public health impact . PhD thesis Royal Veterinary and Agricultural University; Copenhagen, Denmark:
  16. Ito Y., Moriwaki H., Muto Y., Kato N., Watanabe K., Ueno K. 1997; Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficile . J Med Microbiol 46:80–84 [CrossRef]
    [Google Scholar]
  17. La Ragione R. M., Best A., Clifford D., Weyer U., Johnson L., Marshall R. N., Marshall J., Cooley W. A., Farrelly S. other authors 2006; Influence of colostrum deprivation and concurrent Cryptosporidium parvum infection on the colonization and persistence of Escherichia coli O157 : H7 in young lambs. J Med Microbiol 55:819–828 [CrossRef]
    [Google Scholar]
  18. Meyerholz D. K., Stabel T. J., Ackermann M. R., Carlson S. A., Jones B. D., Pohlenz J. 2002; Early epithelial invasion by Salmonella enterica Serovar Typhimurium DT104 in the swine ileum. Vet Pathol 39:712–720 [CrossRef]
    [Google Scholar]
  19. Rabiu B. A., Jay A. J., Gibson G. R., Rastall R. A. 2001; Synthesis and fermentation properties of novel galacto-oligosaccharides by β -galactosidases from Bifidobacterium species. Appl Environ Microbiol 67:2526–2530 [CrossRef]
    [Google Scholar]
  20. Sako T., Matsumoto K., Tanaka R. 1999; Recent progress on research and applications of non-digestible galacto-oligosaccharides. Int Dairy J 9:69–80 [CrossRef]
    [Google Scholar]
  21. Santos R. L., Zhang S., Tsolis R. M., Kingsley R. A., Adams L. G., Bäumler A. J. 2001; Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 3:1335–1344 [CrossRef]
    [Google Scholar]
  22. Schnaar R. L. 1991; Glycosphingolipids in cell surface recognition. Glycobiology 1:477–485 [CrossRef]
    [Google Scholar]
  23. Shoaf K., Mulvey G. L., Armstrong G. D., Hutkins R. W. 2006; Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:6920–6928 [CrossRef]
    [Google Scholar]
  24. Smiricky-Tjardes M. R., Grieshop C. M., Flickinger E. A., Bauer L. L., Fahey G. C. Jr 2003; Dietary galactooligosaccharides affect ileal and total-tract nutrient digestibility, ileal and fecal bacterial concentrations, and ileal fermentative characteristics of growing pigs. J Anim Sci 81:2535–2545
    [Google Scholar]
  25. Smith H. W., Halls S. 1967; Observations by the ligated intestinal segment and oral inoculation methods on Escherichia coli infections in pigs, calves, lambs and rabbits. J Pathol Bacteriol 93:499–529 [CrossRef]
    [Google Scholar]
  26. Tzortzis G., Goulas A. K., Gibson G. R. 2005a; Synthesis of prebiotic galactooligosaccharides using whole cells of a novel strain, Bifidobacterium bifidum NCIMB 4117. Appl Microbiol Biotechnol 68:412–416 [CrossRef]
    [Google Scholar]
  27. Tzortzis G., Goulas A. K., Gee J. M., Gibson G. R. 2005b; A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J Nutr 135:1726–1731
    [Google Scholar]
  28. Wales A. D., Clifton-Hadley F. A., Cookson A. L., Dibb-Fuller M. P., La Ragione R. M., Pearson G. R., Woodward M. J. 2002; Production of attaching-effacing lesions in ligated large intestine loops of 6-month-old sheep by Escherichia coli O157 : H7. J Med Microbiol 51:755–763
    [Google Scholar]
  29. WHO 2005 Drug-resistant Salmonella Geneva: World Health Organization;
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.004390-0
Loading
/content/journal/jmm/10.1099/jmm.0.004390-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error